FENC vs Peers Stock Comparison

Fennec Pharmaceuticals Prices as of Oct 26, 2026 Peers: Industry group

Percentile Scorecard

FENC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisFENC
Valuation 59 #255 of 626
Growth 93 #43 of 604
Profitability 84 #88 of 555
Financial Health 57 #285 of 658
Shareholder Returns –
Overall 73
  • FENC ranked among 673 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodFENCSPY
1 month -4.2% -0.8%
3 months -0.6% +3.5%
6 months +48.2% +7.0%
Year to date +31.8% +12.2%
1 year +12.9% +13.0%
3 years +48.4% +86.3%
3 years, per year +14.1% +23.1%
5 years +12.2% +68.6%
5 years, per year +2.3% +11.0%
10 years +415.2% +258.0%
10 years, per year +17.8% +13.6%

Risk

MeasureFENCSPY
Volatility, 1Y 64.1% 12.7%
Downside volatility, 1Y 59.6% 12.7%
Beta vs S&P 500, 1Y 1.32 1.00
Return / volatility, 1Y 0.20 1.02
Max drawdown, 5Y -65.6% -25.4%
From 52-week high -20.6% -1.8%
52-week high $12.78 $779.14
52-week low $5.77 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleFENC
P/E now vs peer median -53.1xmedian 17.1x
P/S now vs peer median 6.6xmedian 8.8x
EV/EBITDA now vs peer median —median 17.1x
P/FCF now vs peer median —median 18.0x
P/B now vs peer median 8.4xmedian 2.1x
PEG now vs peer median -1.25median 0.31

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsFENC
Revenue $53.77M
Gross profit $49.65M
Operating income -$3.74M
Net income -$6.60M
R&D $274.00K
EPS (diluted) $-0.18
Cash & equivalents $41.25M
Shares (diluted) 36.43M
Enterprise value $236.91M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricFENC
P/E -53.1x
P/FCF –
P/Operating cash flow –
P/S 6.6x
P/B 8.4x
P/Tangible book 8.4x
EV/EBITDA –
EV/EBIT -84.1x
EV/Revenue 5.8x
EV/FCF –
EV/Operating cash flow –
PEG (3Y EPS CAGR) -1.25

Growth

14 metrics
MetricFENC
Revenue growth (1Y) 61.4%
Revenue CAGR (3Y) 118.1%
Gross profit growth (1Y) 65.9%
Gross profit CAGR (3Y) –
Operating income growth (1Y) 61.4%
Operating income CAGR (3Y) 46.2%
Net income growth (1Y) 45.1%
Net income CAGR (3Y) 37.0%
EPS growth (1Y) 58.3%
EPS CAGR (3Y) 42.6%
Operating cash flow growth (1Y) –
Operating cash flow CAGR (3Y) –
Free cash flow growth (1Y) –
Free cash flow CAGR (3Y) –

Profitability

14 metrics
MetricFENC
Gross margin 92.4%
EBITDA margin –
Operating margin -7.0%
Pretax margin -8.2%
Net margin -12.3%
FCF margin –
Operating cash flow margin –
Return on equity -11.4%
Return on assets -6.1%
Return on invested capital –
Return on capital employed -6.2%
Asset turnover 0.7x
Cash conversion (OCF / net income) –
Stock comp / revenue 14.8%

Financial Health

11 metrics
MetricFENC
Debt / assets –
Debt / equity –
Net debt / EBITDA –
Debt / FCF –
Liabilities / assets 44.0%
Equity / assets 56.0%
Interest coverage -2.5x
Current ratio 5.8x
Quick ratio 5.2x
Cash ratio 3.3x
Altman Z-score 3.70

Shareholder Returns

7 metrics
MetricFENC
Dividend yield –
Net buyback yield –
Shareholder yield –
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusFENC
Forward P/E 35.0xFY2026
EPS, next fiscal year $0.29FY2026
EPS growth, the year after +241.4%
Revenue, next fiscal year $75.58MFY2026
Revenue growth, next FY +69.3%FY2026
Revenue growth, the year after +28.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersFENC
Held by institutions 46.6%
Institutions holding 107
Change in shares held, QoQ +0.7%
Institutions buying 71
Institutions selling 19
Buyers to sellers 3.74

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.